| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.62▲ | 2.62▲ | 2.64▼ | 2.70▼ | 2.51▲ |
| MA10 | 2.62▲ | 2.65▼ | 2.69▼ | 2.66▼ | 2.61▲ |
| MA20 | 2.63▲ | 2.70▼ | 2.73▼ | 2.60▲ | 2.57▲ |
| MA50 | 2.71▼ | 2.72▼ | 2.68▼ | 2.62▲ | 2.66▼ |
| MA100 | 2.73▼ | 2.66▼ | 2.68▼ | 2.55▲ | 4.34▼ |
| MA200 | 2.70▼ | 2.65▼ | 2.49▲ | 2.49▲ | 11.18▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | -0.013▼ | -0.021▼ | 0.014▲ | 0.019▲ |
| RSI | 37.185▼ | 32.135▼ | 37.745▼ | 51.544▲ | 49.922▼ |
| STOCH | 33.333 | 8.579▼ | 3.867▼ | 58.394 | 24.401 |
| WILL %R | -20.000▲ | -88.235▼ | -90.476▼ | -61.765 | -90.038▼ |
| CCI | 125.959▲ | -75.615 | -113.741▼ | -26.352 | -21.767 |
|
Tuesday, August 04, 2026 01:30 AM
When issued U.S. patent protection until at least October 2044 -- -- Allowed patent adds to already issued enobosarm specific molecule ...
|
|
Thursday, June 04, 2026 07:22 AM
Veru Inc. (NASDAQ:VERU) has entered into a clinical supply agreement with Novo Nordisk A/S (NYSE:NVO) to support its upcoming Phase 2b PLATEAU study, which will investigate a combination treatment for ...
|
|
Thursday, June 04, 2026 07:22 AM
Veru Inc. (NASDAQ:VERU) has entered into a clinical supply agreement with Novo Nordisk A/S (NYSE:NVO) to support its upcoming Phase 2b PLATEAU study, which will investigate a combination treatment for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/08/26 | 2.72 | 2.72 | 2.61 | 2.63 | 71,825 |
| 27/08/26 | 2.82 | 2.84 | 2.72 | 2.74 | 122,545 |
| 26/08/26 | 2.73 | 2.82 | 2.70 | 2.80 | 168,856 |
| 25/08/26 | 2.60 | 2.79 | 2.60 | 2.71 | 227,019 |
| 24/08/26 | 2.50 | 2.61 | 2.50 | 2.61 | 101,190 |
| 21/08/26 | 2.56 | 2.68 | 2.5563 | 2.64 | 177,451 |
| 20/08/26 | 2.65 | 2.6793 | 2.52 | 2.58 | 135,422 |
| 19/08/26 | 2.60 | 2.66 | 2.59 | 2.64 | 138,670 |
| 18/08/26 | 2.61 | 2.63 | 2.54 | 2.59 | 109,605 |
| 17/08/26 | 2.70 | 2.71 | 2.6138 | 2.63 | 126,953 |
|
|
||||
|
|
||||
|
|